Lyudmila Boyanova
Overview
Explore the profile of Lyudmila Boyanova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
967
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boyanova L, Gergova R, Markovska R
Anaerobe
. 2025 Feb;
92:102949.
PMID: 40010487
Coculture systems (CCSs) are experimental tools used to study the interactions of anaerobic bacteria among themselves and the gut epithelial cells under conditions simulating the human gut, unlike those in...
2.
Casas Deza D, Alcedo J, Lafuente M, Lopez F, Perez-Aisa A, Pavoni M, et al.
Am J Gastroenterol
. 2025 Feb;
PMID: 39902822
Introduction: To evaluate the prescription patterns, effectiveness, and safety of adding probiotics to Helicobacter pylori eradication therapy, in Europe. Methods: International, prospective, noninterventional registry of the clinical practice of the...
3.
Stankova P, Boyanova L, Atanasova D, Mihaylova S, Sredkova M, Gergova R, et al.
Microorganisms
. 2024 Sep;
12(9).
PMID: 39338452
The aim of the present work was to genetically characterise cefotaxime-resistant enterobacteria isolated from community carriers in Bulgaria. In total, 717 faecal samples from children and adults in five medical...
4.
Boyanova L, Boyanova L, Hadzhiyski P, Gergova R, Markovska R
Anaerobe
. 2024 Aug;
89:102897.
PMID: 39154706
Oxygen tolerance of anaerobes is a virulence factor, but can also be a beneficial property. Many species have evolved to tolerate or take advantage of the presence of low, especially...
5.
Markovska R, Stankova P, Popivanov G, Gergova I, Mihova K, Mutafchiyski V, et al.
Antibiotics (Basel)
. 2024 Jul;
13(7).
PMID: 39061359
The rapid spread of carbapenemase-producing strains has led to increased levels of resistance among Gram-negative bacteria, especially enterobacteria. The current study aimed to collect and genetically characterize the colistin- and...
6.
Boyanova L, Medeiros J, Yordanov D, Gergova R, Markovska R
Lett Appl Microbiol
. 2024 May;
77(6).
PMID: 38794899
Non-antibiotic adjuncts may improve Helicobacter pylori infection control. Our aim was to emphasize curcumin benefits in controlling H. pylori infection. We discussed publications in English mostly published since 2020 using...
7.
Huguet J, Ferrer-Barcelo L, Suarez P, Barcelo-Cerda S, Sempere J, Saracino I, et al.
United European Gastroenterol J
. 2024 Apr;
12(6):691-704.
PMID: 38685613
Background: Adherence to Helicobacter pylori (H. pylori) eradication treatment is a cornerstone for achieving adequate treatment efficacy. Objective: To determine which factors influence compliance with treatment. Methods: A systematic prospective...
8.
Markovska R, Stankova P, Stoeva T, Keuleyan E, Mihova K, Boyanova L
Antibiotics (Basel)
. 2024 Jan;
13(1).
PMID: 38247640
To solve the problem with pan-drug resistant and extensively drug-resistant Gram-negative microbes, newly approved drugs such as ceftazidime/avibactam, cefiderocol, plazomicin, meropenem/vaborbactam, and eravacycline have been introduced in practice. The aim...
9.
Bujanda L, Nyssen O, Ramos J, Bordin D, Tepes B, Perez-Aisa A, et al.
Am J Gastroenterol
. 2023 Nov;
119(4):646-654.
PMID: 37983769
Introduction: Antibiotic resistance is one of the main factors that determine the efficacy of treatments to eradicate Helicobacter pylori infection. Our aim was to evaluate the effectiveness of first-line and...
10.
Jonaitis P, Nyssen O, Saracino I, Fiorini G, Vaira D, Perez-Aisa A, et al.
Sci Rep
. 2023 Nov;
13(1):18821.
PMID: 37914853
No abstract available.